About
David Cull received his medical doctorate from Baylor College of Medicine in Houston, Texas, and completed his residency in general surgery at Wilford Hall Medical Center in San Antonio, Texas. He was a vascular surgery fellow at Eastern Virginia Graduate School of Medicine in Norfolk, Virginia. He is a fellow of the American College of Surgeons, the Southern Surgical Association, the Southern Association for Vascular Surgery, the Society for Vascular Surgery, the Peripheral Vascular Surgery Society, and the Southeastern Surgical Congress. For more information, see his Faculty Profile.
How their research is transforming health care
David has over 25 years of experience in vascular access surgery and with the management of vascular access complications. Heis also an inventor and entrepreneur. In 2004, he founded and served as chief technical officer for CreatiVasc Medical Inc., a company focused on delivering innovative technologies that reduce vascular access complications and improve the quality of life for patients with end stage renal disease. CreatiVasc Medical was recently acquired by Brookhaven Medical Inc. David has over a dozen issued and pending U.S. and international patents for devices he has invented in the field of vascular access and wound management. Currently he is the chief medical officer for Hapta Medical LLC, a start-up medical device company. He has participated as the principal investigator or as the medical director for a number of industry-sponsored clinical trials evaluating devices related to vascular access and vascular surgery. Since 2007, he has served as a member of the Cardiovascular Advisory Panel for the Food and Drug Administration. He has published nearly 100 articles and book chapters related to his clinical research.
Health research keywords
Vascular Access Procedure Selection, Complex Vascular Access, Vascular Interventions for Limb Salvage
